LABT earnings analysis
What we found in LABT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided 10-Q extract does not include the income statement, balance sheet, cash-flow statement, segment data, or quantitative operating outlook, so revenue, margins, EPS, liquidity balances, and free cash flow cannot be assessed from the filing text supplied. The company received approximately $6.8 million of net financing proceeds, but 497,157 Series C preferred shares remained outstanding and carry a 12.0% cumulative dividend with conversion pricing potentially as low as $1.00. The most material negative is that disclosure controls remained ineffective as of June 30, 2026 due to four material weaknesses, which management expects to remediate over time without assurance of full or timely resolution.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- $6.8M of financing proceeds
- The April 21, 2026 preferred-stock financing generated approximately $6.8 million of net proceeds after fees and offering expenses, providing additional liquidity.
- Nasdaq listing completed
- The company listed on Nasdaq on April 23, 2026, but issued 27,273 common shares to the placement agent valued at $2,359,080, representing a substantial non-cash listing-related cost.
- Preferred conversions progressed
- Through June 30, 2026, the holder converted 440,343 Series C preferred shares; 497,157 preferred shares remained outstanding at quarter-end.
- No derivative exposure
- The company states that it does not hold derivative instruments and does not engage in hedging activities.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Material weaknesses remain unresolved
- Management concluded disclosure controls were not effective as of June 30, 2026 because of four identified material-weakness areas, including limited documentation, limited segregation of duties, insufficient management review, and ineffective IT general controls.
- Preferred-stock dilution and dividend burden
- The Series C preferred stock carries cumulative dividends of 12.0% annually, and 497,157 shares remained outstanding at June 30, 2026, creating ongoing financing costs and potential dilution.
- Variable-price conversion risk
- Series C conversion pricing can be as low as the $1.00 floor price and is based on 80% of the lowest closing sale price over the preceding five trading days, subject to the stated terms, increasing potential dilution if the share price declines.
- Remediation timing is uncertain
- The company says remediation of the control weaknesses is expected to occur over time because of limited personnel and financial resources, with no assurance that remediation will be timely or fully effective.
What they said about what is next.
The provided 10-Q extract contains no quantitative revenue or EPS outlook. No explicit guidance change is disclosed.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 22, 2026
- The provided 10-Q text does not include the income statement, balance sheet, cash-flow statement, MD&A operating discussion, or segment results, so revenue, margins, EPS, cash burn, and period-over-period trends cannot…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing LABT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever